Zepbound (tirzepatide) and Wegovy (semaglutide) are FDA-approved injectable medications revolutionizing weight management. Both belong to the incretin mimetic drug class but differ in their mechanisms ...

PHILADELPHIA — Roux-en-Y gastric bypass (RYGB) produces maximal weight loss in patients with obesity compared with other surgical procedures and with weight loss drugs, according to a meta-analysis ...

New evidence comparing weight gain under eight different first-line antidepressants finds that bupropion users are 15–20% less likely to gain a clinically significant amount of weight than users of ...

Dear Miss Manners: In 2011, I had weight loss surgery. It was very successful, and I’ve managed to keep the weight off. Of course, a lot of people think I “took the easy way” to lose weight, but ...

A new study compared weight change across eight common first-line antidepressants for patients taking an antidepressant for the first time. The study found differences in weight change between the ...

Glucagon-like peptide-1 (GLP-1) receptor agonists were originally prescribed for type 2 diabetes (T2D), but several are now specifically approved for long-term weight management. Comparing how well ...

Over the past few years, medications like Ozempic and Mounjaro have revolutionized the treatment of Type 2 diabetes and obesity — and they’ve soared in popularity as a result. Studies have shown the ...